通过专为投资者打造的一站式数据看板，全面查看 InMed Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

4.63M

股息TTM

0.00

市盈率 TTM

-0.66

每股收益TTM

-2.12

营业收入

净利润

-8.16M

净资产收益率

-112.65%

总资产收益率

-85.12%

InMed Pharmaceuticals Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

财务指标

每股收益

-3.70%-1.24

62.14%-0.73

85.93%-0.51

99.19%-0.44

70.32%-1.20

46.01%-1.94

1.71%-3.64

-254.97%-54.11

-98.36%-4.04

70.15%-3.58

79.70%-3.71

81.20%-15.24

---2.04

---12.01

---18.27

---81.10

----

营业收入

----

-26.22%820.19K

-11.43%1.12M

1.69%1.30M

7.59%1.26M

-10.36%1.11M

40.23%1.26M

-44.48%1.28M

13.41%1.17M

163.99%1.24M

181.14%901.86K

348.96%2.31M

233.97%1.03M

77.22%469.78K

--320.79K

--514.76K

--309.58K

--265.09K

----

净利润

-226.53%-5.84M

-39.86%-2.97M

21.23%-2.03M

-2.92%-1.73M

7.71%-1.79M

-23.10%-2.12M

-74.20%-2.58M

33.86%-1.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

95.70%-338.39K

42.52%-2.00M

50.94%-2.10M

-18.12%-3.51M

-141.50%-7.87M

-12.06%-3.48M

-90.87%-4.28M

-85.83%-2.97M

利润率

----

-6.76%-247.29%

-16.20%-154.17%

9.24%-137.07%

-14.42%-168.12%

-94.34%-231.63%

52.83%-132.68%

-931.39%-151.02%

23.97%-146.93%

73.35%-119.19%

74.29%-281.29%

---14.64%

---193.24%

---447.25%

---1094.24%

----

毛利率

----

-56.45%15.97%

2.82%31.24%

25.26%40.15%

-71.88%5.63%

69.13%36.67%

915.80%30.38%

-51.16%32.06%

45.91%20.01%

24.05%21.68%

97.79%-3.72%

--65.64%

--13.72%

--17.48%

---168.36%

----

利润表

营业收入

----

-26.22%820.19K

-11.43%1.12M

1.69%1.30M

7.59%1.26M

-10.36%1.11M

40.23%1.26M

-44.48%1.28M

13.41%1.17M

163.99%1.24M

181.14%901.86K

348.96%2.31M

233.97%1.03M

77.22%469.78K

--320.79K

--514.76K

--309.58K

--265.09K

----

营业利润

-74.32%-3.21M

-36.62%-2.82M

3.88%-2.12M

-0.54%-1.76M

8.31%-1.84M

-17.77%-2.12M

-29.41%-2.21M

33.16%-1.75M

-289.14%-2.01M

16.43%-1.80M

23.69%-1.70M

24.57%-2.62M

83.06%-516.26K

39.28%-2.15M

45.67%-2.23M

-20.28%-3.48M

7.83%-3.05M

-12.95%-3.54M

-112.59%-4.11M

-84.96%-2.89M

净利润

-226.53%-5.84M

-39.86%-2.97M

21.23%-2.03M

-2.92%-1.73M

7.71%-1.79M

-23.10%-2.12M

-74.20%-2.58M

33.86%-1.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

95.70%-338.39K

42.52%-2.00M

50.94%-2.10M

-18.12%-3.51M

-141.50%-7.87M

-12.06%-3.48M

-90.87%-4.28M

-85.83%-2.97M

资产负债表

流动资产

-79.20%2.68M

7.46%6.89M

60.67%8.79M

48.35%10.80M

48.08%12.87M

-36.31%6.41M

-53.68%5.47M

-12.24%7.28M

-23.32%8.69M

-15.02%10.06M

-15.75%11.81M

-28.14%8.30M

18.07%11.33M

35.39%11.84M

12.10%14.02M

-27.75%11.54M

14.56%9.60M

-19.73%8.75M

22.01%12.51M

--15.98M

流动负债总额

6.27%1.96M

20.25%2.21M

-17.36%1.48M

8.29%1.55M

-6.70%1.84M

20.29%1.84M

6.57%1.79M

7.22%1.44M

-1.44%1.97M

-32.64%1.53M

-30.00%1.68M

-59.19%1.34M

-39.73%2.00M

-44.72%2.27M

-48.01%2.40M

70.32%3.28M

49.84%3.32M

139.49%4.11M

114.42%4.62M

--1.93M

总资产

-80.55%3.03M

-1.57%9.13M

31.63%11.19M

27.67%13.36M

31.78%15.58M

-30.53%9.28M

-44.27%8.50M

-4.14%10.47M

-16.19%11.82M

-9.31%13.36M

-9.84%15.26M

-25.14%10.92M

10.31%14.11M

-4.88%14.73M

-12.71%16.92M

-15.83%14.58M

30.74%12.79M

25.44%15.49M

65.00%19.38M

--17.33M

总负债

-8.88%1.96M

-0.72%2.24M

-30.88%1.60M

-14.46%1.77M

-18.00%2.15M

0.19%2.26M

-6.57%2.32M

54.54%2.07M

29.76%2.62M

-3.77%2.25M

-3.92%2.48M

-62.55%1.34M

-45.63%2.02M

-49.07%2.34M

-50.45%2.58M

69.85%3.58M

54.24%3.71M

138.23%4.60M

25.50%5.22M

--2.11M

总权益

-92.00%1.08M

-1.85%6.89M

55.09%9.59M

38.06%11.59M

45.93%13.43M

-36.77%7.02M

-51.60%6.18M

-12.35%8.40M

-23.85%9.21M

-10.36%11.10M

-10.90%12.77M

-12.99%9.58M

33.17%12.09M

13.79%12.39M

1.18%14.34M

-27.68%11.01M

23.07%9.08M

4.53%10.89M

86.64%14.17M

--15.22M

现金流量表

经营净额

-77.39%-3.15M

-82.14%-3.02M

5.03%-2.38M

12.00%-1.61M

-72.81%-1.78M

14.21%-1.66M

-35.39%-2.50M

15.98%-1.83M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

-101.75%-4.05M

-15.99%-5.35M

---3.53M

-93.49%-2.65M

投资净额

--0.00

100.00%0.00

--0.00

100.00%0.00

100.00%-2.00

98.14%-9.29K

--0.00

95.37%-33.61K

-3508.16%-128.20K

-263.39%-500.00K

100.00%0.00

-41955.48%-725.46K

---3.55K

--306.01K

---250.00K

融资净额

-100.00%-1.00

-92.07%231.68K

-100.00%0.00

-116.37%-137.18K

4644531.25%8.17M

--2.92M

-92.73%338.52K

--838.24K

--176.00

100.00%0.00

-12.44%4.65M

-100.00%0.00

-117.31%-63.70K

735.69%5.32M

-50.12%5.43M

6172.97%5.05M

-100.72%-29.31K

---836.14K

16936.86%10.88M

常见问题

InMed Pharmaceuticals Inc的流动资产是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，流动资产为2.68M（同比变化-79.20）。

InMed Pharmaceuticals Inc的总资产是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，InMed Pharmaceuticals Inc的总资产为3.03M（同比变化-80.55）。

InMed Pharmaceuticals Inc的总负债是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，InMed Pharmaceuticals Inc的总负债为1.96M（同比变化-8.88）。

InMed Pharmaceuticals Inc的总权益是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，InMed Pharmaceuticals Inc的总权益为1.08M（同比变化-92.00）。

InMed Pharmaceuticals Inc的净营业收入是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，InMed Pharmaceuticals Inc的净营业收入为-9.90M（同比变化-24.97）。

InMed Pharmaceuticals Inc的净融资是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，InMed Pharmaceuticals Inc的净融资为94.50K（同比变化-99.23）。

InMed Pharmaceuticals Inc的每股收益（EPS）是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，每股收益（EPS）为-3.02（同比变化63.93）。

InMed Pharmaceuticals Inc的净利润是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，净利润为-12.56M（同比变化-53.89）。

InMed Pharmaceuticals Inc的股东权益回报率（ROE）是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，股东权益回报率（ROE）为-156.77（同比变化-117.43）。

InMed Pharmaceuticals Inc的资产回报率（ROA）是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，资产回报率（ROA）为-122.23（同比变化-105.17）。

InMed Pharmaceuticals Inc的营业利润是多少？



根据InMed Pharmaceuticals Inc的FY2026财报，营业利润为-9.90M（同比变化-24.97）。